Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Famotidine and Treatment of COVID-19 Patients
Rahmani, F.; Salmasi, S.; Bakhtavar, H. E..
ARCHIVES OF CLINICAL INFECTIOUS DISEASES ; 16(6), 2022.
Article in English | Web of Science | ID: covidwho-1912024
2.
Association Between Preadmission Acid Suppressive Medication Exposure and Severity of Illness in Patients Hospitalized With COVID-19.
Elmunzer, B Joseph; Wolf, Bethany J; Scheiman, James M; Tierney, William M; Taylor, Jason R.
Gastroenterology ; 160(4): 1417-1422.e14, 2021 Mar.
Article in English | MEDLINE | ID: covidwho-1046005

Subject(s)
COVID-19/complications , Histamine H2 Antagonists/adverse effects , Proton Pump Inhibitors/adverse effects , SARS-CoV-2 , Adult , Aged , COVID-19/mortality , Female , Hospitalization , Humans , Male , Middle Aged , Retrospective Studies , Severity of Illness Index
3.
Famotidine Use Is Associated With Improved Clinical Outcomes in Hospitalized COVID-19 Patients: A Propensity Score Matched Retrospective Cohort Study.
Freedberg, Daniel E; Conigliaro, Joseph; Wang, Timothy C; Tracey, Kevin J; Callahan, Michael V; Abrams, Julian A.
Gastroenterology ; 159(3): 1129-1131.e3, 2020 09.
Article in English | MEDLINE | ID: covidwho-327210

Subject(s)
Betacoronavirus , Coronavirus Infections/drug therapy , Famotidine/therapeutic use , Histamine H2 Antagonists/therapeutic use , Pneumonia, Viral/drug therapy , Adult , Aged , COVID-19 , Coronavirus Infections/mortality , Coronavirus Infections/virology , Female , Humans , Male , Middle Aged , Pandemics , Pneumonia, Viral/mortality , Pneumonia, Viral/virology , Propensity Score , Retrospective Studies , SARS-CoV-2 , Treatment Outcome , COVID-19 Drug Treatment
SEND TO:
Email
Export
Print
RSS
XML
SELECTION OF CITATIONS
SEARCH DETAIL